Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: unbearable (2), impossible (30), painful (166)

Consent for a cannula

Description: Consent for a cannula
Url: /HealthProfessionals/Clinical-law-updates/Consent-for-a-cannula.aspx

Enzalutamide

Description: Chemotherapy Protocol PROSTATE ENZALUTAMIDE Regimen • Prostate-Enzalutamide Indication • Enzalutamide is recommended
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Enzalutamide.pdf

Darolutamide

Description: Chemotherapy Protocol PROSTATE CANCER DAROLUTAMIDE Regimen • Prostate - Darolutamide Indication • Darolutamide is r
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Darolutamide.pdf

Afatinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Regimen AFATINIB NSCLC - Afatinib Indication Treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AfatinibVer1.pdf

Vemurafenib Ver 1

Description: Chemotherapy Protocol SKIN CANCER Regimen VEMURAFENIB Skin – Vemurafenib Indication Vemurafenib is recommended as an option for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinVemurafenibVer1.pdf

Dabrafenib Ver 1

Description: Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Panitumumab (21 day) Ver 1.1

Description: Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

Mobocertinib

Description: A chemotherpay document based on Mobocertinib.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Mobocertinib.pdf

Paclitaxel (7 day)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL (7 day) Regimen • Breast Cancer – Paclitaxel (7 day) Indication • Treatment of locall
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-7-day.pdf

Panitumumab (14 day) Ver 1.2

Description: Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (14 day) This regimen may require funding Regimen Colorecta
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab14dayVer12.pdf

1 to 10 of 21

Previous 1 2 3 Next